Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)

NCT05854784 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Variegate Porphyria

Interventions

DRUG: Afamelanotide 16 MG

Sponsor

Clinuvel Pharmaceuticals Limited